LAKE FOREST, Ill., Jan. 10 /PRNewswire-FirstCall/ -- Hospira, Inc. , one of the largest hospital products manufacturers in the United States, today announced that Christopher B. Begley, chief executive officer, and John Arnott, senior vice president, Global Commercial Operations, will present a company overview at the JPMorgan 23rd Annual Healthcare Conference on Wednesday, Jan. 12, 2005, at The Westin St. Francis Hotel in San Francisco.
The presentation will be open to all interested parties at noon Eastern Time on Wednesday, Jan. 12, 2005, through a live webcast of the conference call in the investor relations section of Hospira’s Web site, http://www.hospira.com/ . Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the webcast. A replay will be available on the Hospira Web site approximately 24 hours after the live presentation for 30 days following the call. In addition, the slides accompanying the presentation will be available on the Hospira Web site, beginning at noon.
About Hospira
Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM) by developing, manufacturing and marketing products that help improve the safety and efficacy of patient care. Created from the core global hospital products business of Abbott Laboratories, Hospira is a new company with 70 years of service to the hospital industry. The company’s portfolio includes one of the industry’s broadest lines of generic acute-care injectables, which help address the high cost of proprietary pharmaceuticals in hospitals; integrated solutions for medication management and infusion therapy; and a full-service contract manufacturing business. Headquartered in Lake Forest, Ill., north of Chicago, Hospira has more than 14,000 employees and 15 manufacturing facilities worldwide. Hospira’s news releases and other information can be found at http://www.hospira.com/ .
Private Securities Litigation Reform Act of 1995 -- A Caution Concerning Forward-Looking Statements
Some statements in this news release may be forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. Hospira cautions that these forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Hospira’s operations and may cause actual results to be materially different from expectations include the risks and uncertainties set forth in the information statement under the heading “Risk Factors” in the most recent version of the Form 10 filed with the Securities and Exchange Commission, which are incorporated by reference. Hospira undertakes no obligation to release publicly any revisions to forward-looking statements as the result of subsequent events or developments.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.comHospira, Inc.
CONTACT: Media, Stacey Eisen, +1-224-212-2276, or Financial Community,Lynn McHugh, +1-224-212-2363, both of Hospira, Inc.